toxicity symptoms and increases in dopac were associated with higher brain concentrations for type i ( 2.6-5.8 micrograms/gm ) than type ii pyrethroids ( 0.4-0.6 micrograms/gm ) .
C0006104
brain
C0086045
concentrations